HRP20050366B1 - Vodotopive granule meloksikama - Google Patents

Vodotopive granule meloksikama

Info

Publication number
HRP20050366B1
HRP20050366B1 HRP20050366AA HRP20050366A HRP20050366B1 HR P20050366 B1 HRP20050366 B1 HR P20050366B1 HR P20050366A A HRP20050366A A HR P20050366AA HR P20050366 A HRP20050366 A HR P20050366A HR P20050366 B1 HRP20050366 B1 HR P20050366B1
Authority
HR
Croatia
Prior art keywords
meloxicam
water
granulates
soluble meloxicam
soluble
Prior art date
Application number
HRP20050366AA
Other languages
English (en)
Croatian (hr)
Inventor
Martin Andreas Folger
Stefan Henke
Jens Schmalz
Diana Christine Keilhofer
Hans-Juergen Kroff
Nina Herz
Original Assignee
Boehringer Ingelheim Vetmedica Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Vetmedica Gmbh filed Critical Boehringer Ingelheim Vetmedica Gmbh
Publication of HRP20050366A2 publication Critical patent/HRP20050366A2/xx
Publication of HRP20050366B1 publication Critical patent/HRP20050366B1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A61K31/5415—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame ortho- or peri-condensed with carbocyclic ring systems, e.g. phenothiazine, chlorpromazine, piroxicam
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Molecular Biology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Biophysics (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Oncology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Non-Alcoholic Beverages (AREA)
  • Medicines Containing Plant Substances (AREA)
HRP20050366AA 2002-10-25 2003-10-24 Vodotopive granule meloksikama HRP20050366B1 (hr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE10250081A DE10250081A1 (de) 2002-10-25 2002-10-25 Wasserlösliche Meloxicam Granulate
PCT/EP2003/011802 WO2004037264A1 (de) 2002-10-25 2003-10-24 Wasserlösliche meloxicam granulate

Publications (2)

Publication Number Publication Date
HRP20050366A2 HRP20050366A2 (en) 2006-06-30
HRP20050366B1 true HRP20050366B1 (hr) 2013-12-06

Family

ID=32103087

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20050366AA HRP20050366B1 (hr) 2002-10-25 2003-10-24 Vodotopive granule meloksikama

Country Status (27)

Country Link
US (1) US20130005714A1 (https=)
EP (1) EP1558262B1 (https=)
JP (2) JP4856377B2 (https=)
KR (1) KR101152689B1 (https=)
CN (1) CN1708307B (https=)
AR (1) AR041717A1 (https=)
AT (1) ATE381337T1 (https=)
AU (1) AU2003276170B2 (https=)
BR (1) BR0315639A (https=)
CA (1) CA2503396C (https=)
CO (1) CO5570680A2 (https=)
CY (1) CY1107298T1 (https=)
DE (2) DE10250081A1 (https=)
DK (1) DK1558262T3 (https=)
ES (1) ES2298619T3 (https=)
HR (1) HRP20050366B1 (https=)
MX (1) MXPA05004211A (https=)
MY (1) MY136901A (https=)
PE (1) PE20040495A1 (https=)
PL (1) PL212425B1 (https=)
PT (1) PT1558262E (https=)
RU (1) RU2333744C2 (https=)
TW (1) TWI336622B (https=)
UA (1) UA81785C2 (https=)
UY (1) UY28039A1 (https=)
WO (1) WO2004037264A1 (https=)
ZA (1) ZA200502702B (https=)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
CN1680427B (zh) * 2005-02-01 2010-08-11 杨喜鸿 易于水溶解的匹多莫德复盐及其制备方法
WO2007011349A1 (en) * 2005-07-15 2007-01-25 Teva Pharmaceutical Industries Ltd. Novel granulation process and granulate produced therefrom
AU2006298895B9 (en) * 2005-09-30 2013-01-24 Boehringer Ingelheim Vetmedica Gmbh Pharmaceutical preparation containing meloxicam
US7572641B2 (en) 2005-11-22 2009-08-11 Teva Pharmaceutical Industries Ltd. Pharmaceutical compositions comprising meloxicam and methods of their preparation
US7772255B2 (en) * 2005-12-13 2010-08-10 Supratek Pharma, Inc. Method of treating tumors with azaxanthones
KR100791160B1 (ko) * 2006-05-30 2008-01-02 조선대학교산학협력단 멜록시캄의 에탄올아민염 및 이를 함유하는 약제학적조성물
JP2010083826A (ja) * 2008-10-01 2010-04-15 Nihon Generic Co Ltd オキシカム系化合物を含む固形製剤を製造する方法
TR200809200A1 (tr) * 2008-12-01 2009-12-21 Sanovel �La� Sanay� Ve T�Caret Anon�M ��Rket� Meloksikam içeren farmasötik formülasyonlar
MX389960B (es) 2009-10-12 2025-03-20 Boehringer Ingelheim Vetmedica Gmbh Recipientes para composiciones que comprenden meloxicam.
CA2791805A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
RU2465892C1 (ru) * 2011-09-21 2012-11-10 Федеральное государственное бюджетное образовательное учреждение высшего профессионального образования "Новосибирский национальный исследовательский государственный университет (НГУ)" Способ получения высокодисперсного мелоксикама
CN103705479B (zh) * 2012-09-29 2017-11-28 瑞普（天津）生物药业有限公司 一种宠物用美洛昔康缓释片及其制备方法
RU2559000C1 (ru) * 2014-02-25 2015-08-10 Вячеслав Михайлович Спиридонов Кормовая добавка бфк
US9526734B2 (en) * 2014-06-09 2016-12-27 Iceutica Pty Ltd. Formulation of meloxicam
WO2016086114A1 (en) * 2014-11-25 2016-06-02 Artdem, Llc Sports drink formulation
US20170281640A1 (en) * 2016-04-04 2017-10-05 Productos Maver, S.A. De C.V. Pharmaceutical Compositions Containing a Muscle Relaxant and a Nonsteroidal Anti-Inflammatory Drugs (NSAID)
EP3541815A4 (en) 2016-11-18 2020-07-15 Pacira Pharmaceuticals, Inc. ZINC MELXICAM COMPLEX MICROPARTICLE MULTIVESICULAR LIPOSOME FORMULATIONS AND METHODS OF MAKING THE SAME
JP2019163249A (ja) * 2018-03-16 2019-09-26 フジタ製薬株式会社 メロキシカム水性溶液

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
WO2001097812A1 (fr) * 2000-06-20 2001-12-27 Fujisawa Pharmaceutical Co., Ltd. Preparations pharmaceutiques contenant des composes tetracycliques

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS52102416A (en) * 1976-02-19 1977-08-27 Okawara Mfg Granule making method of herb medicine and like
DE3218150C2 (de) * 1982-05-14 1986-09-25 Akzo Gmbh, 5600 Wuppertal Wirkstoff enthaltender Körper für die Langzeitabgabe sowie Verfahren zu dessen Herstellung
JPH0753663B2 (ja) * 1984-10-09 1995-06-07 武田薬品工業株式会社 チアミン塩の顆粒，その製造法および錠剤
IT1207994B (it) * 1986-01-03 1989-06-01 Therapicon Srl Sali idrosulubili di composti adattivita' antiinfiammatoria ed analgesica, loro preparazione ed utilizzo in composizioni farmaceutiche.
US5654003A (en) * 1992-03-05 1997-08-05 Fuisz Technologies Ltd. Process and apparatus for making tablets and tablets made therefrom
JPH0912426A (ja) * 1995-06-29 1997-01-14 Asahi Chem Ind Co Ltd 吸湿性物質組成物
US6106862A (en) * 1998-08-13 2000-08-22 Andrx Corporation Once daily analgesic tablet
DE19859636A1 (de) * 1998-12-23 2000-06-29 Hexal Ag Kontrolliert freisetzende pharmazeutische Zusammensetzung mit Tilidinmesylat als Wirkstoff
US6685928B2 (en) * 1999-12-07 2004-02-03 Rutgers, The State University Of New Jersey Therapeutic compositions and methods
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
DE10250081A1 (de) * 2002-10-25 2004-05-13 Boehringer Ingelheim Vetmedica Gmbh Wasserlösliche Meloxicam Granulate

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0945134A1 (de) * 1998-03-27 1999-09-29 Boehringer Ingelheim Pharma KG Neue galenische Zubereitungsformen von Meloxicam zur oralen Applikation
WO2001097812A1 (fr) * 2000-06-20 2001-12-27 Fujisawa Pharmaceutical Co., Ltd. Preparations pharmaceutiques contenant des composes tetracycliques

Also Published As

Publication number Publication date
DK1558262T3 (da) 2008-01-28
EP1558262A1 (de) 2005-08-03
ATE381337T1 (de) 2008-01-15
ES2298619T3 (es) 2008-05-16
EP1558262B1 (de) 2007-12-19
KR101152689B1 (ko) 2012-06-15
DE10250081A1 (de) 2004-05-13
MY136901A (en) 2008-11-28
BR0315639A (pt) 2005-08-30
JP2011213726A (ja) 2011-10-27
AR041717A1 (es) 2005-05-26
CA2503396C (en) 2011-12-13
CY1107298T1 (el) 2012-11-21
AU2003276170B2 (en) 2009-07-16
ZA200502702B (en) 2008-01-30
PL375479A1 (en) 2005-11-28
HRP20050366A2 (en) 2006-06-30
CN1708307B (zh) 2011-12-07
HK1084878A1 (en) 2006-08-11
US20130005714A1 (en) 2013-01-03
DE50308863D1 (de) 2008-01-31
CA2503396A1 (en) 2004-05-06
UY28039A1 (es) 2004-05-31
UA81785C2 (uk) 2008-02-11
TWI336622B (en) 2011-02-01
CO5570680A2 (es) 2005-10-31
AU2003276170A1 (en) 2004-05-13
PE20040495A1 (es) 2004-09-17
PT1558262E (pt) 2008-01-18
KR20050070079A (ko) 2005-07-05
MXPA05004211A (es) 2005-06-08
JP5579132B2 (ja) 2014-08-27
TW200501961A (en) 2005-01-16
JP2006505574A (ja) 2006-02-16
RU2333744C2 (ru) 2008-09-20
CN1708307A (zh) 2005-12-14
JP4856377B2 (ja) 2012-01-18
RU2005115955A (ru) 2006-02-10
WO2004037264A1 (de) 2004-05-06
PL212425B1 (pl) 2012-09-28

Similar Documents

Publication Publication Date Title
HRP20050366A2 (en) Water-soluble meloxicam granulates
DE60305509D1 (de) Formulierungen enthaltend wasserlösliche granulate
DE60220174D1 (de) Herbizidzusammensetzungen umfassend imidazolinonsäure
MX2008014740A (es) Derivados de 2-arilpirazolo[1,5-alfa]pirimidina-3-il acetamida como ligandos para la proteina translocadora (18 kda).
AR054511A1 (es) Una composicion que comprende emtricitabina y tenofovir df granuladas en seco
ME02508B (me) Deuterisani derivati kateholamina i medikamenti koji obuhvataju pomenuta jedinjenja
CL2011002918A1 (es) Composicion farmaceutica solida que comprende al inhibidor de quinasa aurora acido 4-{[9-cloro-7-(2-fluoro-6-metoxifenil)-5h-pirimido-[5,4-d][2]benzazepin-2-il]amino}-2-metoxibenzoico, una sal o una forma cristalina del mismo; metodo para prepararla que incluye un proceso de granulacion en humedo.
NO20032271L (no) GABA-enhancere i behandlingen av sykdommer relatert til redusert nevrosteroidaktivitet
PL1697345T3 (pl) Benzymidazole zawierające morfolinyl, jako inhibitory replikacji wirusa zespólni układu oddechowego
DE60008935D1 (de) Pyridinsulfonylharnstoffderivate mit herbizider wirkung
DK1401422T3 (da) Halogenholdig sammensætning, fremgangsmåde til fremstilling heraf og anvendelser heraf
ATE316782T1 (de) Neue orale formulierungen für 5-ht4 agonisten oder antagonisten
BR0210912A (pt) Compostos e composições como inibidores de catepsina
MEP15708A (en) Lithium complexes of n-(1-hydroxymethyl-2,3-dihydroxypropyl)-1,4,7-triscarboxymethyl-1,4,7,10-tetraazacyclododecane, production and use thereof
MEP34708A (en) Macrolide-conjugates with anti-inflammatory activity
HRP20060136A2 (en) Pellets containing venflaxine hydrochloride
NO20064190L (no) Preparat for oral administrering av tamsulosin-hydroklorid og granuler med kontrollert frigivelsesformulering omfattende det samme
UY29445A1 (es) Composiciones para la transmisión transmucosa oral de la metformina
DE60123464D1 (de) Zusammensetzung aus natrium, kalium, calcium und magnesium
EA200600954A1 (ru) Способ приготовления гранул мочевины
WO2007022445A3 (en) Treatment of chronic renal failure and other conditions in domestic animals: compositions and methods
EA200600173A1 (ru) Диспергируемая во рту фармацевтическая композиция антитромботического соединения
NO20052562L (no) Anvendelse av distrontiumsalter av 2-[N,N-di(karboksylmetyl)amino]-3-cyano-4-karboksylmetyl-tiofen-5-karboksylsyre for fremstilling av medikamenter for behandlingen av gastro-duodenal smerte.
EA201792104A1 (ru) Водно-диспергируемые гранулы монензина, получаемые влажной грануляцией
ATE392213T1 (de) Verwendung von gamma-gt inhibitoren zur behandlung von chronischen degenerativerkrankungen

Legal Events

Date Code Title Description
A1OB Publication of a patent application
ARAI Request for the grant of a patent on the basis of the submitted results of a substantive examination of a patent application
ODRP Renewal fee for the maintenance of a patent

Payment date: 20130927

Year of fee payment: 11

B1PR Patent granted
PBON Lapse due to non-payment of renewal fee

Effective date: 20141024